This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / US AI Health Insurance Regulation Debate
Regulatory regulatory debate

US AI Health Insurance Regulation Debate

Analysis based on 8 articles · First reported Feb 18, 2026 · Last updated Feb 25, 2026

Sentiment
0
Attention
6
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The ongoing regulatory debate over AI in health insurance creates uncertainty for companies like The Cigna Group and UnitedHealth Group, potentially increasing compliance costs and affecting their stock prices. The federal push for innovation without 'cumbersome regulation' clashes with state-level efforts to impose guardrails, leading to a fragmented regulatory landscape that could hinder national AI adoption strategies for insurers.

Health Insurance Technology
Event Summary

A politically divisive debate is unfolding in the United States regarding the regulation of Artificial Intelligence (AI) in health insurance. President Donald Trump's administration is pushing for AI integration and issued an executive order to preempt state-level regulations, arguing for innovation without 'cumbersome regulation.' In contrast, several states, including United States — Arizona, United States — Maryland, United States — Nebraska, United States — Texas, United States — Illinois, and United States — California, have enacted or are considering legislation to restrict AI use in health insurance, particularly concerning claims denials and prior authorizations. Governors like Ron DeSantis of Florida and Gavin Newsom of United States — California have taken different approaches, with Ron DeSantis proposing an 'AI Bill of Rights' and Gavin Newsom balancing consumer protection with tech industry interests. Health insurers such as The Cigna Group and UnitedHealth Group are facing scrutiny and lawsuits over their AI-powered claims processes, while industry groups like AHIP (trade association) advocate for a consistent national AI policy framework. Legal scholars, such as Carmel Shachar, question the constitutionality of Donald Trump's executive order, highlighting the tension between federal and state powers in this emerging regulatory field.

Entities Involved
stock
The Cigna Group
The Cigna Group's CEO denied using AI for denials, but the company is being sued for its claims-denial methods, which ProPublica spotlighted.
Importance 70.0 Sentiment -20.0
subs
UnitedHealth Group — Optum
UnitedHealth Group — Optum, a part of UnitedHealth Group, announced the rollout of tech-powered prior authorization, aiming for speedier approvals.
Importance 50.0 Sentiment 10.0
per
Alex Bores
Alex Bores, a New York Assembly member, advocates for AI regulation, noting the inscrutability of insurance company answers.
Importance 40.0 Sentiment 0.0
loc
United States — Nebraska
United States — Nebraska is one of the states that enacted legislation last year to restrict the use of AI in health insurance.
Importance 40.0 Sentiment 0.0
loc
United States — Rhode Island
Legislators in United States — Rhode Island plan to reintroduce a bill requiring regulators to collect data on technology use after a previous attempt failed.
Importance 40.0 Sentiment 0.0
ngo
Alliance of Community Health Plans
The Alliance of Community Health Plans, a trade group, views the bills as a regulatory burden that diverts resources from patient care.
Importance 30.0 Sentiment 0.0
per
Linda Ujifusa
Linda Ujifusa, a Democratic state senator in United States — Rhode Island, faced opposition from insurers for her bill to restrict AI use in coverage denials.
Importance 30.0 Sentiment 0.0
govactor
United States — United States House Committee on Ways and Means
The United States — United States House Committee on Ways and Means questioned health insurance executives about affordability and AI use in claims.
Importance 30.0 Sentiment 0.0
ngo
American Medical Association
The American Medical Association supports state regulations for greater accountability and transparency from health insurers using AI.
Importance 30.0 Sentiment 0.0
per
Daniel Schwarcz
Daniel Schwarcz, a University of Minnesota law professor, highlights the limitations of state laws in regulating self-insured plans and the ambiguity of human oversight requirements for AI decisions.
Importance 20.0 Sentiment 0.0
per
Chris Micheli
Chris Micheli, a lobbyist, explains Gavin Newsom's balanced approach to AI regulation in United States — California, considering both consumer protection and the state budget's reliance on tech companies.
Importance 20.0 Sentiment 0.0
per
Carmel Shachar
Carmel Shachar, a Harvard Law School scholar, suggests Donald Trump's executive order to preempt state AI regulation is likely unconstitutional.
Importance 20.0 Sentiment 0.0
ngo
ProPublica
ProPublica's reporting highlighted the use of algorithms to deny insurance claims, influencing the debate.
Importance 20.0 Sentiment 0.0
stock
UnitedHealth Group
Importance 0.0 Sentiment 0.0
loc
United States — Arizona
Importance 0.0 Sentiment 0.0
+ 12 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.